James Signorovitch

14PUBLICATIONS
63CO-AUTHORS
Gene and molecular therapyNeurology and neuromuscular diseasesRespiratory diseasesMajor global burdens of diseaseMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 04, 2026
Five-Year Outcomes With Delandistrogene Moxeparvovec in Patients With Duchenne Muscular Dystrophy: A Phase 1/2a Study.

|Mar 20, 2026
Motor Function and Growth Outcomes With Early Corticosteroid Initiation in Duchenne Muscular Dystrophy: An Adjusted Cross-Trial Comparison.

Emma Ciafaloni, Abigail Zion, Joanne Donovan

|Jul 18, 2025
Real-world phosphorodiamidate morpholino oligomer treatment patterns in Duchenne muscular dystrophy: a claims-based analysis.

Shannon Grabich, Brian Ung, Aalok Nadkar

|Jun 27, 2025
Predicting trajectories of the north star ambulatory assessment total score in Duchenne muscular dystrophy.

Francesco Muntoni, James Signorovitch, Nathalie Goemans

|Mar 12, 2025
Treatment patterns and healthcare resource utilization in ruxolitinib-treated patients with myelofibrosis with and without anemia: a real-world analysis.

Tom Liu, Mirko Fillbrunn, Shiyuan Zhang

|Nov 11, 2024
Assessment of Phosphorodiamidate Morpholino Oligomer Treatment Patterns for Patients with Duchenne Muscular Dystrophy: A MarketScan Claims Analysis.

Alexa C Klimchak, James Signorovitch, Bryan Innis

Pageof 3

Frequent Collaborators

2 joint publications

Craig McDonald

2 joint publications

Susan J Ward

2 joint publications

Erik H Niks

2 joint publications

Nicolae Done